Lab properties are rebounding in the real estate market, driven by the increasing demand for spaces that cater to both tech and biomanufacturing companies. According to a recent JLL report, properties that are move-in ready and equipped with the necessary amenities are attracting tenants, marking a significant shift in the commercial real estate landscape.
What Happened
JLL's latest report highlights a resurgence in the demand for lab properties, specifically those that are ready to accommodate the needs of tech companies with dry labs and biomanufacturing firms with wet labs. This trend is particularly evident in urban centers where the demand for specialized lab space is high. The report underscores the importance of properties being move-in ready, which is becoming a critical factor for companies looking to quickly establish their operations without the delay of extensive buildouts.
The lab real estate market, which had seen a downturn, is now witnessing a recovery as companies ramp up their research and development activities. The increased focus on biotechnology and pharmaceuticals, propelled by the pandemic, has accelerated this demand. With the right amenities, these properties are not just filling space; they are becoming hubs of innovation and collaboration.
What This Means for Your Business
For businesses in the AECM sector, this trend presents a lucrative opportunity. Companies that can offer turnkey solutions for lab spaces, including the necessary infrastructure for both dry and wet labs, stand to gain significantly. This could mean increased contracts for construction and engineering firms that specialize in lab buildouts.
Moreover, the focus on amenities implies a need for advanced HVAC systems, specialized plumbing, and enhanced security measures, which are critical for compliance and safety in lab environments. This opens up avenues for companies providing these services to expand their offerings and capture a larger market share.
For government contractors, there is potential to tap into federal funding aimed at bolstering domestic biomanufacturing capabilities. This could involve partnerships with tech and biopharma companies that are looking to establish or expand their operations within the U.S.
What US Operators Should Watch
Decision-makers should keep an eye on upcoming procurement windows and federal funding opportunities that support the development of lab spaces. Staying informed about changes in compliance requirements and safety standards, such as those outlined by the National Institute of Standards and Technology (NIST) and the Cybersecurity Maturity Model Certification (CMMC), will be crucial.
Additionally, as the market for lab properties grows, competition is likely to increase. Companies should consider investing in cutting-edge technologies and sustainable practices to differentiate their offerings and meet the evolving demands of tenants.
Source: https://www.facilitiesdive.com/news/amenities-pull-in-tenants-as-lab-properties-recover-jll/822603/
Is your firm ready for what’s next?
VisioneerIT helps AECM and government contractors modernize operations, achieve compliance, and implement AI.
Explore VisioneerIT Solutions →
